| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $636.5M | +23.9% |
| R&D Expense | $253.7M | -9.5% |
| SG&A Expense | $230.9M | +8.7% |
| Operating Income | -$172.9M | +32.6% |
| Income Tax | $185K | +72.9% |
| Net Income | -$128.6M | +46.5% |
| EPS (Basic) | -$1.44 | +49.8% |
| EPS (Diluted) | -$1.44 | +49.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $788.4M | +114.0% |
| Total Assets | $2.37B | +17.3% |
| Total Liabilities | $1.73B | +25.5% |
| Stockholders' Equity | $633.2M | -0.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $186.3M | +216.1% |
| Capital Expenditures | $837K | -45.2% |
| Investing Cash Flow | -$237.7M | -100.7% |
| Financing Cash Flow | $559.9M | +161.3% |
| Free Cash Flow | $185.5M | +214.5% |